Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 509 participants.

Also called NCT01294163

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 509 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01294163
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
France, Germany, Italy, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01294163. Randomized; single masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-12-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
Condition
General Anesthetic Drug Allergy
Condition
Coronary Artery Bypass Graft Surgery
Intervention (Drug)
Xenon
Intervention (Drug)
Sevoflurane
Intervention (Drug)
Propofol
Lead sponsor
Air Liquide Santé International (class: industry)
Collaborator
Orion Corporation, Orion Pharma (class: industry)

Record details

Record id
cardio:ct-nct01294163
Content hash
6b0ef4dcf96f69b4c71db291a36c01bcfdbab29f32bad91cb59135204ea8ebea